Diminished renal function and the incidence of heart failure

Johan Arnlöv1

  • 1Department of Public Health and Caring Sciences, Uppsala University, Uppsala, and the Department of Health and Social Sciences, Högskolan Dalarna, Falun, Sweden.

Insights

Diminished renal function is a significant risk factor for heart failure across the general population and in high-risk groups. This review explores the link between kidney function decline and heart failure incidence.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Heart failure is a prevalent and serious condition with significant healthcare costs.
  • Several markers of kidney function, including creatinine-based glomerular filtration rate, cystatin C, and albuminuria, are established independent risk factors for heart failure.

Purpose of the Study:

  • To review the current understanding of the relationship between reduced kidney function and heart failure incidence.
  • To examine this relationship in both the general community and in high-risk populations (e.g., cardiovascular disease, hypertension, diabetes).
  • To identify key areas for future research in this field.

Main Methods:

  • This is a review article.
  • It synthesizes existing knowledge from published studies.
  • Focuses on epidemiological data and clinical observations.

Main Results:

  • Diminished renal function is consistently associated with an increased risk of developing heart failure.
  • This association is observed across diverse populations, including those with pre-existing cardiovascular conditions, hypertension, and diabetes.
  • Specific renal function indices like glomerular filtration rate, cystatin C, and albuminuria are highlighted as crucial indicators.

Conclusions:

  • There is a strong and well-established link between impaired kidney function and heart failure.
  • Understanding this relationship is critical for risk stratification and management of heart failure patients.
  • Further research is needed to elucidate underlying mechanisms and optimize interventions.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...